BARRETT & COMPANY, INC. - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 1 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2023. The put-call ratio across all filers is - and the average weighting 14.2%.

Quarter-by-quarter ownership
BARRETT & COMPANY, INC. ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2023$294
-29.5%
3000.0%0.00%
Q2 2023$417
-12.6%
3000.0%0.00%
Q1 2023$477
-74.5%
3000.0%0.00%
-100.0%
Q4 2022$1,8690.0%3000.0%0.00%0.0%
Q3 2022$1,8693000.00%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q4 2023
NameSharesValueWeighting ↓
Meditor Group Ltd 2,818,835$33,967,00011.67%
PLATINUM INVESTMENT MANAGEMENT LTD 1,713,176$20,644,0000.58%
Bellevue Group AG 4,519,164$54,455,0000.55%
Rhenman & Partners Asset Management AB 622,267$7,498,0000.53%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 47,534$573,0000.21%
WASATCH ADVISORS LP 3,274,360$39,456,0000.16%
EMC Capital Management 27,566$246,0000.14%
PDT Partners, LLC 120,828$1,456,0000.10%
Virtus ETF Advisers LLC 17,773$214,0000.09%
Pinz Capital Management, LP 15,300$184,0000.08%
View complete list of ESPERION THERAPEUTICS INC NE shareholders